Clinical Trials
WHAT IT TAKES — Central Nervous System (CNS) Clinical Trials
Biopharmaceutical companies developing new CNS products can face special obstacles.
Patient Centricity — taking care of our most valuable asset!
“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient fi
Because who Doesn’t Love a Quiz!
Randomized comparative bioavailability of a novel 3D printed fast melt formulation of levetiracetam following the administration of a single 1000 mg dose to healthy human volunteers under fasting and fed conditions
What Effect Will the New NIH Policy Have On Multi-Site Research?
In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a
What Does it Take? | First in Human Clinical Trials
Does the CRO you’re working with have what it takes to successfully conduct First-in-Human (FIH) clinical research?
What Does it Take? | Biologic and Biosimilar Clinical Trials
It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here).
What Really Happens in a Clinical Lab – Part 2
Last week we talked about our awesome lab staff who are responsible for sample collection and processing during a clinical trial.
Volunteers Are Heroes
Recruiting volunteers for a clinical trial is vital to its success, but once volunteers are in house it’s paramount to retain them through the length of the study. This could be one night or it could be weeks. Also, there could be one in-house period or several where the volunteer must return to the clinic again and again for several over-night stays.
So, the question as a clinical research site is, how do we keep our study volunteers happy and retain them for the length of the trial?
A Phase IB Clinical Study to Evaluate the Analgesic Effect of GIC-1001 And GIC-1002 on Visceral Pain Under Rectal Distension Using the Barostat Method in Healthy Volunteers